EquityFlow
›
Companies
› Xyall
Xyall
Healthtech
· Eindhoven, NL
Dutch medtech automating tissue dissection for molecular pathology diagnostics.
Funding history
Date
Round
Amount
Jun 2022
Series B
Eindhoven molecular-pathology medtech Xyall raised a 6M euro Series B to commercialise its Tissector tissue-dissection systems.
$6M
Similar companies in Healthtech
OurMind
TurnUp
Nanordica Medical
Uncovr
01Health
Rem3dy Health
Joyvié Health
Semble
Triomics
Musely
VITL
Ema Health
Explore funding flow on EquityFlow →